Arch Therapeutics Inc (ARTH)

[Polyphemus]

J&J has a large range of products in the wound care sector. One of them, Dermabond Topical Skin Adhesive, is established at a low price. Dermabond is sold to hospitals and MD offices, and can also be purchased at Walgreen's and CVS. What would be the angle for J&J to distribute this product or acquire ARTH?

AC5 seems to be a similar product to Dermabond in that it is cleared for topical use and acts quickly as a sealant, will stop minor bleeding. Is AC5 strong enough to hold wounds together for 5-10 days, as product info for Dermabind states?-I have no information, just asking questions. Take a look at Dermabond on the web. There is also a new product in this space, just cleared by FDA and being introduced by Bergen Medical - Actabond. Does anyone have reliable info on the issue of comparative perfiormance or positioning? Please chime in.